Biotech Values

[masterlongevity]

dimebon may have a better channe in mod to severe as it is easier to show movement earlier in later stage disease (quickly declining placebo pts).

for disease modifying therapies, earlier is better. but that is not necessarily true for symptomatic drugs like dimebon